Delivery Order SPE2DB25D3017-SPE2DB25FVKQU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg under a firm fixed price contract valued at $3,938.90, with completion scheduled for August 8, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, likely for military or veteran healthcare systems managed through DLA's medical supply chain. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,534.28 for 60 mg Brilinta tablets (60-count) on August 27, 2025, with completion scheduled for August 28, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg, a pharmaceutical product used in cardiovascular treatment, under a firm fixed-price contract valued at $1,266.36. The award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,451.98 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a non-competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on August 5, 2025, with a ceiling value of $1,468.41. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.39 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,169.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. This order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and was competitively awarded....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,552.14 to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count packaging). This firm fixed-price, competitively awarded contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $2,496.78 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, firm fixed-price contract reflects a non-set-aside procurement and represents a routine pharmaceutical supply transaction under the company's existing federal contracting relationships. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) under a firm fixed price contract valued at $5,184.10. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 20, 2025. AmerisourceBergen will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKQUDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.68 for 60 mg tablets of Brilinta (ticagrelor), an antiplatelet medication, with an ultimate completion date of September 15, 2025. This is a firm fixed price delivery order issued under a non-competitive set-aside arrangement. The contract is being performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As one of the primary pharmaceutical suppliers supporting the Defense Health Agency and military healthcare systems globally, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order exemplifies the company's role in supporting federal medical procurement needs for military and veteran healthcare systems through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/12/25 |